Despite its advantages, targeted therapy is not without limitations. One major challenge is the development of resistance, where cancer cells may alter their structure or function to evade the effects of treatment. Additionally, targeted therapies are often specific to certain types of cancer, meaning that not all patients will be eligible for this treatment. Furthermore, the high cost of targeted cancer drugs can be a barrier to access for some patients.
